A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2002
10/22/2002	US6468964 Administering to human or animal active agent capable of preventing or controlling acid and endotoxin accumulation in gastrointestinal tract, selected from antibiotics, enzymes, clays, probiotics, compounds which slow rate of passage
10/22/2002	US6468963 Methods and formulations for reducing toxicity associated with diabetes treatments
10/22/2002	US6468962 Nutritional intervention composition for enhancing and extending satiety
10/22/2002	US6468961 Gel composition and methods
10/22/2002	US6468960 Therapeutic compositions and methods for enhancing angiogenesis
10/22/2002	US6468959 Dry pellets for oral or nasal administration comprising peptide drug having given net charge dispersed in matrix selected from gelatin, gelatin derivatives and/or collagen hydrolyzates having opposite charge to form pseudocoacervate
10/22/2002	US6468798 Liposome-nucleic acid complexes are prepared then delivered via aerosol to the lung airway; for transforming pulmonary cells and treating lung diseases
10/22/2002	US6468796 Antisense oligonucleotides; gene therapy; diagnosis
10/22/2002	US6468795 Apoptotic protease activating factor (apaf-1); hybridizable antisense oligonucleotides; gene expression inhibition
10/22/2002	US6468791 Chromosone 1 gene and gene products related to Alzheimer's disease
10/22/2002	US6468778 Process for the inactivation of viruses
10/22/2002	US6468768 Identification of novel galectins which can serve as useful tools in the development of therapeutics and diagnostics for regulating immune response
10/22/2002	US6468767 DNA encoding a human dopamine D1 receptor and uses thereof
10/22/2002	US6468766 Aortic carboxypeptidase-like polypeptide
10/22/2002	US6468755 Method for identifying compounds for treatment of insulin resistance
10/22/2002	US6468546 Compositions and methods for therapy and diagnosis of ovarian cancer
10/22/2002	US6468545 Helicobacter pylori catalase.
10/22/2002	US6468543 Administering protein comprising a first polypeptide disulfide-bonded to a second polypeptide, polypeptides comprise amino acid residues 258-370 of seq id no:2 and said protein is mitogenic or chemotactic for mesenchymal cells
10/22/2002	US6468540 Immunotherapeutic stress protein-peptide complexes against cancer
10/22/2002	US6468539 Protein targeting into HIV virions based on HIV-1 VPR fusion molecules
10/22/2002	US6468537 Nucleosome histone protein
10/22/2002	US6468536 Proteins extracted with perchloric acid from animal organs for preparation of medicaments active against autoimmune diseases, such as atherosclerosis, arthritis, multiple sclerosis, and diabetes; proteins uk 101 and uk 114; sequence
10/22/2002	US6468535 Increasing the muscle mass in an animal by administering an antibody, or antigen-binding fragment of said antibody, which binds to and inhibits the activity of gdf-8 polypeptide
10/22/2002	US6468534 Methods for obtaining transfer factor from avian sources, compositions including avian-generated transfer factor, and methods of use
10/22/2002	US6468533 Polyclonal or monoclonal antibody that inhibits high mobility group 1 protein mediated activation of inflammatory cytokine cascade; sepsis
10/22/2002	US6468531 Method of promoting cellular function
10/22/2002	US6468530 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
10/22/2002	US6468529 Fab fragment of a monoclonal antibody; binds to c-met receptor; cancer treatment
10/22/2002	US6468503 Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic precipitates in the cancer
10/22/2002	CA2246754C Cochleate delivery vehicles
10/22/2002	CA2216601C Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/22/2002	CA2185712C Enhanced virus-mediated dna transfer
10/22/2002	CA2147989C Enhancement of xenograft tolerance and porcine cytokines therefor
10/22/2002	CA2095335C Cell growth inhibitors
10/22/2002	CA2040437C Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor
10/22/2002	CA2022437C Reduced size lhrh analogs
10/22/2002	CA1341395C Preparation of functional human factor viii
10/20/2002	CA2382326A1 Therapeutic use of selective pde10 inhibitors
10/17/2002	WO2002082091A2 Method for identification of proteins from intracellular bacteria
10/17/2002	WO2002082077A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
10/17/2002	WO2002082076A2 Renal cell carcinoma tumor markers
10/17/2002	WO2002082075A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
10/17/2002	WO2002082074A1 Intranasal delivery of agents for regulating development of implanted cells in the cns
10/17/2002	WO2002082044A2 Method of imaging cell death in vivo
10/17/2002	WO2002081751A2 A method of increasing endogenous leptin production
10/17/2002	WO2002081747A1 Method of examining steroid responsiveness
10/17/2002	WO2002081745A2 Genes involved in osteogenesis, and methods of use
10/17/2002	WO2002081720A1 Polysubstituted polycarboxylic phosphoamide biopolymers, methods for their production and uses of compositions derived therefrom
10/17/2002	WO2002081706A2 Regulation of human phosphatase-like protein
10/17/2002	WO2002081705A2 Regulation of human gnat acetyltransferase-like protein
10/17/2002	WO2002081704A2 Regulation of human protein kinase-like protein
10/17/2002	WO2002081703A2 Mitogenic oxygenase regulators
10/17/2002	WO2002081693A1 Production, composition and usage of a recombinant hormones system for superovulation in vertebrates and invertebrates
10/17/2002	WO2002081692A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/17/2002	WO2002081691A2 Abcg5 and abcg8: compositions and methods of use
10/17/2002	WO2002081690A1 Novel protein, dna thereof and use of the same
10/17/2002	WO2002081689A1 Regulation of human cyclic nucleotide-gated channel ocnc2 subunit
10/17/2002	WO2002081688A1 Dna molecules encoding igb3 synthase, and uses thereof for the disruption of glycosyltransferase genes in xenotransplantation tissues and organs
10/17/2002	WO2002081687A2 Yeast genes that affect viral replication
10/17/2002	WO2002081684A2 Antisense calpain nucleotides and uses thereof
10/17/2002	WO2002081674A1 Alpha-galactosidase as food-grade genetic marker
10/17/2002	WO2002081671A1 Novel human kinase and polynucleotides encoding the same
10/17/2002	WO2002081649A2 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF
10/17/2002	WO2002081648A2 Synthesis and secretion of recombinant lysosomal enzymes by liver
10/17/2002	WO2002081646A2 Epitope sequences
10/17/2002	WO2002081645A2 Cp27 peptides and their use in modulating cell growth and apoptosis
10/17/2002	WO2002081642A2 Gene brcc-3 and diagnostic and therapeutic uses thereof
10/17/2002	WO2002081641A2 Gene scc-112 and diagnostic and therapeutic uses thereof
10/17/2002	WO2002081640A2 Gene shinc-1 and diagnostic and therapeutic uses thereof
10/17/2002	WO2002081639A2 Gene brcc2 and diagnostic and therapeutic uses thereof
10/17/2002	WO2002081636A2 Protein modification and maintenance molecules
10/17/2002	WO2002081628A2 Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies
10/17/2002	WO2002081627A2 Methods of screening and using inhibitors of angiogenesis
10/17/2002	WO2002081625A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/17/2002	WO2002081621A2 Vaccine against the nile fever virus
10/17/2002	WO2002081619A1 Glycosaminoglycan/collagen complexes and use thereof
10/17/2002	WO2002081521A2 Osteoprotegerin in milk
10/17/2002	WO2002081520A2 Single chain dimeric polypeptides derived from the vegf family
10/17/2002	WO2002081519A2 Ifn-thy fusion protein,dna coding therefore,its preparation and application
10/17/2002	WO2002081518A2 Proteins, polynucleotides encoding them and methods of using the same
10/17/2002	WO2002081517A2 Novel polypeptides and nucleic acids encoded thereby
10/17/2002	WO2002081515A1 Insulin-like growth factor-binding protein
10/17/2002	WO2002081514A2 A novel f-box protein
10/17/2002	WO2002081513A2 Disease-associated protein
10/17/2002	WO2002081510A2 Proteins, polynucleotides encoding them and methods of using the same
10/17/2002	WO2002081507A2 Interferon gamma polypeptide variants
10/17/2002	WO2002081506A1 Process for producing trunkamide a compounds
10/17/2002	WO2002081505A2 Peptide for the diagnosis and therapy of alzheimer's disease
10/17/2002	WO2002081504A2 Multimerization of hiv-1 vif protein as a therapeutic target
10/17/2002	WO2002081503A1 Novel substances k97-0239 and process for producing the same
10/17/2002	WO2002081499A2 Somatostatin agonists
10/17/2002	WO2002081495A1 Antisense modulation of phospholipid scramblase i expresion
10/17/2002	WO2002081494A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
10/17/2002	WO2002081460A1 Lipid lowering biphenylcarboxamides
10/17/2002	WO2002081413A2 One dimensional unichemo protection (ucp) in organic synthesis
10/17/2002	WO2002080987A1 Anti-cd19 immunotoxins
10/17/2002	WO2002080982A2 Nucleic acid mucosal immunization
10/17/2002	WO2002080979A2 Conjugate of hydroxyalkyl starch and an active agent
10/17/2002	WO2002080976A2 Hsa-free formulations of interferon-beta
10/17/2002	WO2002080973A1 Composition for use in therapy of hard tissue of mammal and method of therapy thereof

1 ... 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 ... 3163